Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension
European Journal of Internal Medicine · 2023
DOI: 10.1016/j.ejim.2023.01.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2023. Verfasst von Rui Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Antiphospholipid Syndrome, Thrombophilia, Pulmonary Embolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua.
Abstract (Originalsprache)
Acquired thrombophilia and in particular the presence of antiphospholipid antibodies (aPL) may play an important role in the development of chronic thromboembolic pulmonary hypertension (CTEPH). Young patients suffering from an episode of unprovoked pulmonary embolism (PE), or PE provoked by mild risk factors, should be tested for aPL. In case of a positive result, they should be closely followed up and lifelong anticoagulant treatment should be considered. Indeed, aPL-induced thrombophilia may favor PE recurrence with the consequence of possible CTEPH development. The aPL profiles play an important role in this pathway. Patients with PE and triple positivity (lupus anticoagulant, LAC, anti-cardiolipin, aCL, and anti-β2-glycoprotein I, aβ2GPI) are at the highest risk of recurrence and deserve maximum protection by anticoagulant treatment with warfarin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China.
- Department of Cardiac Surgery, The First Affiliated Hospital of XiaMen University, XiaMen, China.
- Department of Cardio-Thoracic-Vascular Sciences and Public Health, Thrombosis Research Laboratory, University of Padua, Padua, Italy.
- Department of Cardio-Thoracic-Vascular Sciences and Public Health, Thrombosis Research Laboratory, University of Padua, Padua, Italy; Arianna Foundation on Anticoagulation, Bologna, Italy. Electronic address: vittorio.p…
Förderung
- University of Padua
Zitieren
APA
Zhu, R., Cheng, G. Y., Denas, G., & Pengo, V. (2023). Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2023.01.012
Vancouver
Zhu R, Cheng GY, Denas G, Pengo V. Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension. European Journal of Internal Medicine. 2023. doi:10.1016/j.ejim.2023.01.012
BibTeX
@article{Zhu2023,
author = {Zhu, Rui and Cheng, Gang-Yi and Denas, Gentian and Pengo, Vittorio},
title = {Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension},
journal = {European Journal of Internal Medicine},
year = {2023},
doi = {10.1016/j.ejim.2023.01.012}
}
EUVIMED